These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 32432388)

  • 1. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
    Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
    Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
    Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.
    Deshmukh V; O'Green AL; Bossard C; Seo T; Lamangan L; Ibanez M; Ghias A; Lai C; Do L; Cho S; Cahiwat J; Chiu K; Pedraza M; Anderson S; Harris R; Dellamary L; Kc S; Barroga C; Melchior B; Tam B; Kennedy S; Tambiah J; Hood J; Yazici Y
    Osteoarthritis Cartilage; 2019 Sep; 27(9):1347-1360. PubMed ID: 31132406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.
    Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Lattermann C; Skrepnik N; Swearingen CJ; Simsek I; Ghandehari H; DiFrancesco A; Gibbs J; Tambiah JRS; Hochberg MC
    Osteoarthritis Cartilage; 2021 May; 29(5):654-666. PubMed ID: 33588087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Patient-Reported Outcomes From Sham and Saline-Based Placebo Injections for Knee Osteoarthritis: Data From a Randomized Clinical Trial of Lorecivivint.
    Tambiah JRS; Simsek I; Swearingen CJ; Kennedy S; Cole BJ; McAlindon TE; Yazici Y
    Am J Sports Med; 2022 Mar; 50(3):630-636. PubMed ID: 35005990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial.
    Tambiah JRS; Kennedy S; Swearingen CJ; Simsek I; Yazici Y; Farr J; Conaghan PG
    Rheumatol Ther; 2021 Jun; 8(2):973-985. PubMed ID: 34101138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug.
    Sabha M; Siaton BC; Hochberg MC
    Expert Opin Investig Drugs; 2020 Dec; 29(12):1339-1346. PubMed ID: 33096010
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
    Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
    Petrella RJ; Petrella M
    J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.
    McAlindon TE; Schmidt U; Bugarin D; Abrams S; Geib T; DeGryse RE; Kim K; Schnitzer TJ
    Osteoarthritis Cartilage; 2018 Oct; 26(10):1291-1299. PubMed ID: 29753118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Chevalier X; Goupille P; Beaulieu AD; Burch FX; Bensen WG; Conrozier T; Loeuille D; Kivitz AJ; Silver D; Appleton BE
    Arthritis Rheum; 2009 Mar; 61(3):344-52. PubMed ID: 19248129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
    Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
    Karsdal MA; Bihlet A; Byrjalsen I; Alexandersen P; Ladel C; Michaels M; Andersen JR; Riis BJ; Kraus V; Bay-Jensen AC; Christiansen C
    Osteoarthritis Cartilage; 2015 Apr; 23(4):550-8. PubMed ID: 25576879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Diclofenac-Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan.
    Nishida Y; Kano K; Nobuoka Y; Seo T
    Arthritis Rheumatol; 2021 Sep; 73(9):1646-1655. PubMed ID: 33749997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.